![]() Back to Annual Meeting
|
|
![]() Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Neal D. Barnard, MD1, Joshua Cohen, MD1, David J.A. Jenkins, MD, PhD2, Gabrielle Turner-McGrievy, MS, RD3, and Hope Ferdowsian, MD, MPH4. (1) Department of Medicine, George Washington University, 5100 Wisconsin Avenue, Suite 400, Washington, DC 20016, 202-686-2210, ext 303, nbarnard@pcrm.org, (2) University of Toronto, 150 College Street, Room 339, Toronto, ON M5S 3E2, Canada, (3) School of Public Health, University of North Carolina, 5100 Wisconsin Avenue, Suite 400, Washington, DC 20016, (4) Washington Center for Clinical Research, 5100 Wisconsin Avenue, Suite 400, Washington, DC 20016
Diabetes prevalence is increasing at an alarming rate. Prevalence is lower, however, among populations following largely plant-based diets. We previously reported that, in a 22-week trial, a low-fat, vegan diet improved glycemic, lipid, and weight control in persons with type 2 diabetes. We now present final results after an additional year of study (74 weeks total). Individuals with type 2 diabetes were randomly assigned to a low-fat, vegan diet or a diet following American Diabetes Association (ADA) guidelines. Of 99 initial participants, 87 (42 vegan, 45 ADA) completed the full study. A1c changes from baseline to 74 weeks (or to the last value prior to any medication changes) were -0.40 (vegan, P=0.003) and +0.01 (ADA, P=0.47), between-group P=0.03. Among those who met dietary adherence criteria, A1c changes were -0.45 (vegan, N = 21) and -0.31 (ADA, N = 16), P=0.66. Among 74-week completers whose medications remained unchanged, A1c changes were -0.82 (vegan, n=14) and -0.21 (ADA, n=21), P=0.14. Total and LDL cholesterol changes from baseline to 74 weeks (or to last value prior to lipid-lowering medication changes) were: TC: -20.4 mg/dl (vegan), -6.8 mg/dl (ADA); P=0.01; LDL: -14.0 mg/dl (vegan), -3.4 mg/dl (ADA), P=0.03. Weight changes, based on 74-week or last available values, were -4.4 kg (vegan, P<0.0001) and -3.0 kg (ADA, P=0.0003); between-group P=0.25. In conclusion, in individuals with type 2 diabetes in a research setting, a low-fat, vegan diet led to sustained improvements in glycemic, lipid, and weight control.
Learning Objectives:
Presenting author's disclosure statement:
Any relevant financial relationships? Yes
| Name of Organization | Clinical/Research Area | Type of relationship |
|---|---|---|
| Rodale | Book on diet and diabetes | Book publication |
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA